Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03071666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vitamin B12 Supplementation During Pregnancy on Cognitive Development

Study acronym: VitaPreg
StatusActive, Not Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv9
  2. Minor Study completion date: Dec 31, 2024 to Dec 31, 2029v8
  3. Minor Re-verified, no change to tracked fieldsv7
  4. Notable Primary endpoints: 3 to 2
    • Secondary endpoints: 9 to 14
    v6
  5. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Primary completion date: Jun 28, 2021 to Jun 28, 2022
    • Enrollment target: 600 to 800
    • Study completion date: Dec 31, 2021 to Dec 31, 2024
    v4
  2. Minor Re-verified, no change to tracked fieldsv3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 26, 2017 to Mar 27, 2017
    • Site details revised
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Scientific basis: Globally, vitamin B12 deficiency is one of the most common micronutrient deficiencies. The only relevant source of vitamin B12 is animal-source foods and poor gut function may decrease absorption. Vitamin B12 is crucial for normal cell division and differentiation, and necessary for the development and myelination of the central nervous system. Deficiency is also associated with impaired fetal and infant growth. In the proposed study we will measure the effect of daily oral vitamin B12 supplementation to pregnant women on neurodevelopment and growth of their children. We also aim to measure the impact of B12 supplementation on several other outcomes. Study design: Individually randomized double-blind placebo controlled trial in pregnant South Asian women at risk of poor vitamin B12 status. Participants will be randomized in a 1:1 ratio. Study participants and site: 800 pregnant women from early pregnancy. Women will be enrolled as early as possible, but no later than in week 15 of pregnancy. Intervention: Daily administration of 50 µg of vitamin B12 from early pregnancy until 6 months after birth. Comparator: Placebo, identical to the vitamin B12 supplements. Outcomes: Primary: (i) neurodevelopment in children measured at 6 and 12 months of age (ii) growth in children measured by weight and length at 12 months. Secondary: (i) neurodevelopment and cognitive functioning in children at 24 months (ii) gestational age at birth, (iii) fetal and infant growth measured by weight and length at birth, after 1 month and then at 3, 6, 9, and 24 months, (iv) hemoglobin concentration in children and mothers. Relevance for programs and public health: The results from this study can suggest new dietary guidelines for South Asian women that again can lead to improved pregnancy outcomes and neurodevelopment and cognitive functioning in South Asian children.
Trial Details
NCT Number NCT03071666
Lead Sponsor Centre For International Health
Collaborators: Tribhuvan University Teaching Hospital, Institute Of Medicine., NORCE Norwegian Research Centre AS, Sykehuset Innlandet HF
Conditions
(from sponsor)
Pregnancy Related, Vitamin B 12 Deficiency, Anemia
Related terms Anemia, Vitamin B 12 Deficiency
Enrollment 800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov